Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-07-16 | 2022-06-27 |
| Drug Identification Number | 02404761 | 02404761 |
| Brand name | GANCICLOVIR FOR INJECTION | GANCICLOVIR FOR INJECTION |
| Common or Proper name | GANCICLOVIR FOR INJECTION | GANCICLOVIR FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | GANCICLOVIR | GANCICLOVIR |
| Strength(s) | 500MG | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 ML | 10 ML |
| ATC code | J05AB | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2022-07-01 | 2022-07-01 |
| Actual start date | 2022-07-01 | 2022-07-01 |
| Estimated end date | 2022-07-22 | 2022-07-22 |
| Actual end date | 2022-07-15 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production and shipping delays, we will be encountering a supply interruption on our Ganciclovir for Injection 500 mg SD Vial 10 mL effective July 1, 2022 until July 22, 2022. | Fresenius Kabi Canada regrets to advise that due to production and shipping delays, we will be encountering a supply interruption on our Ganciclovir for Injection 500 mg SD Vial 10 mL effective July 1, 2022 until July 22, 2022. |
| Health Canada comments |